PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypogonadism |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 13 |
| PubMedID- 21896895 | Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. |
| PubMedID- 22514541 | These data indicate that testosterone replacement may be important to reduce cardiovascular risk factors, especially in type 2 diabetes associated with the hypogonadism condition. |
| PubMedID- 23798917 | [5–1113] our study has shown that the prevalence of hypogonadism in men with type 2 diabetes is high, especially, if it was defined based on calculated free and bioavailable testosterone. |
| PubMedID- 21709300 | In addition, hypogonadism in men with type 2 diabetes was associated with decreased sexual desire, more symptoms of depression, and lower luteinizing hormone levels. |
| PubMedID- 21982717 | Aim: there is increasing awareness of hypogonadism in men with type 2 diabetes but limited data from primary care. |
| PubMedID- 25394376 | Introduction: the prevalence of hypogonadotropic hypogonadism (hh) in patients with type 2 diabetes mellitus is higher than in the general population and leads to detrimental effects on metabolic control, lipid profile, and body composition. |
| PubMedID- 20150021 | Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus. |
| PubMedID- 23970784 | Male hypogonadism associates with type 2 diabetes, and t can protect pancreatic beta-cells from glucotoxicity. |
| PubMedID- 21386088 | The beneficial effects of trt on overall sexual function and, importantly, libido (a key symptom of testosterone deficiency) support the assessment and treatment of hypogonadism in men with type 2 diabetes and/or mets who do not present specifically with erectile dysfunction. |
| PubMedID- 24222915 | The incidence of hypogonadism among patients with type 2 diabetes was significantly greater in our study than observed in studies cited above. |
| PubMedID- 23153270 | Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and lh secretion in men with type 2 diabetes and mild biochemical hypogonadism. |
| PubMedID- 23881971 | Anti-pituitary antibodies and hypogonadotropic hypogonadism in type 2 diabetes: in search of a role. |
| PubMedID- 22211848 | Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus. |
Page: 1